Signosis is a molecular tools company focused on biomarker discovery and drug development through plate-based assays and stable reporter cell lines.
Founded in 2007 and headquartered in Santa Clara, California, Signosis combines in-house research and development, manufacturing, and quality control to provide platforms for analyzing disease-related proteins, nucleic acids, transcription factors, and signaling pathways. Its custom assay development and stable cell line services address customer-defined pathways and targets, for applications including pathway mapping, compound screening, and translational biomarker validation.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The portfolio includes cytokine and hormone ELISAs, transcription-factor profiling arrays and EMSAs, luciferase reporter vectors, and oxidative stress and disease biomarker combination kits.
Source: LinkedIn company description · Retrieved October 13, 2026
These services address customer-defined pathways and targets for pathway mapping, compound screening, and translational biomarker validation.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.